Literature DB >> 12057152

Brain metastases.

P Y Wen1, J S Loeffler.   

Abstract

Brain metastases are an increasingly common complication in patients with systemic cancer. The optimal treatment for each patient depends on careful evaluation of several factors: the location, size, and number of brain metastases; the patient's age, general condition, and neurologic status; and the extent of systemic cancer to name a few. For patients with a single brain metastasis and limited systemic disease, the standard treatment is surgical resection followed by whole brain radiation therapy. In patients with a small, single metastasis, stereotactic radiosurgery is probably comparable to surgery. Patients with several metastases (up to three) and controlled systemic disease can be treated with whole-brain radiation and stereotactic radiosurgery. Patients with multiple metastases (more than three) are generally treated with whole-brain radiation alone. Radiosurgery is effective in treating patients with a limited number of recurrent brain metastases and stable systemic diseases. Surgery may have a role in patients with a large symptomatic recurrent lesion producing mass effect. Reirradiation and chemotherapy may have a limited role in patients with multiple recurrent metastases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 12057152     DOI: 10.1007/s11864-000-0072-3

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  73 in total

Review 1.  Radiosurgery for the treatment of brain metastases.

Authors:  R F Young
Journal:  Semin Surg Oncol       Date:  1998 Jan-Feb

Review 2.  Whole brain radiotherapy in the treatment of metastatic brain tumors.

Authors:  S S Vermeulen
Journal:  Semin Surg Oncol       Date:  1998 Jan-Feb

Review 3.  An overview of radiotherapy trials for the treatment of brain metastases.

Authors:  L Berk
Journal:  Oncology (Williston Park)       Date:  1995-11       Impact factor: 2.990

4.  Radiosurgery for brain metastases: is whole brain radiotherapy necessary?

Authors:  P K Sneed; K R Lamborn; J M Forstner; M W McDermott; S Chang; E Park; P H Gutin; T L Phillips; W M Wara; D A Larson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-02-01       Impact factor: 7.038

Review 5.  Demographics of brain metastasis.

Authors:  J D Johnson; B Young
Journal:  Neurosurg Clin N Am       Date:  1996-07       Impact factor: 2.509

6.  Reoperation for brain metastases.

Authors:  N Sundaresan; V P Sachdev; G V DiGiacinto; J E Hughes
Journal:  J Clin Oncol       Date:  1988-10       Impact factor: 44.544

7.  Phenytoin-dexamethasone interaction: a previously unreported observation.

Authors:  L A Lawson; R A Blouin; R B Smith; R P Rapp; A B Young
Journal:  Surg Neurol       Date:  1981-07

Review 8.  Radiation response of the central nervous system.

Authors:  T E Schultheiss; L E Kun; K K Ang; L C Stephens
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-03-30       Impact factor: 7.038

Review 9.  Decreased phenytoin levels in patients receiving chemotherapy.

Authors:  S A Grossman; V R Sheidler; M R Gilbert
Journal:  Am J Med       Date:  1989-11       Impact factor: 4.965

10.  Distribution of brain metastases.

Authors:  J Y Delattre; G Krol; H T Thaler; J B Posner
Journal:  Arch Neurol       Date:  1988-07
View more
  15 in total

Review 1.  Management of brain metastasis: past lessons, modern management, and future considerations.

Authors:  Eugene Koay; Erik P Sulman
Journal:  Curr Oncol Rep       Date:  2012-02       Impact factor: 5.075

2.  Brain metastasis from non-seminomatous germ cell tumors of the testis: indications for aggressive treatment.

Authors:  Maurizio Salvati; Manolo Piccirilli; Antonino Raco; Antonino Santoro; Riccardo Frati; Jacopo Lenzi; Gaetano Lanzetta; Antonino Agrillo; Alessandro Frati
Journal:  Neurosurg Rev       Date:  2005-11-23       Impact factor: 3.042

3.  Stereotactic radiosurgical treatment of brain metastasis of primary tumors that rarely metastasize to the central nervous system.

Authors:  Joshua Y Menendez; David F Bauer; Chevis N Shannon; John Fiveash; James M Markert
Journal:  J Neurooncol       Date:  2012-07-03       Impact factor: 4.130

4.  The molecular genomics of metastatic brain tumours.

Authors:  A Bollig-Fischer; Sk Michelhaugh; R Ali-Fehmi; S Mittal
Journal:  OA Mol Oncol       Date:  2013-04-01

Review 5.  Pathobiology of brain metastases.

Authors:  N Nathoo; A Chahlavi; G H Barnett; S A Toms
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

6.  The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases.

Authors:  Paul W Sperduto; T Jonathan Yang; Kathryn Beal; Hubert Pan; Paul D Brown; Ananta Bangdiwala; Ryan Shanley; Norman Yeh; Laurie E Gaspar; Steve Braunstein; Penny Sneed; John Boyle; John P Kirkpatrick; Kimberley S Mak; Helen A Shih; Alex Engelman; David Roberge; Nils D Arvold; Brian Alexander; Mark M Awad; Joseph Contessa; Veronica Chiang; John Hardie; Daniel Ma; Emil Lou; William Sperduto; Minesh P Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-06-14       Impact factor: 7.038

7.  Surgical treatment for brain metastases: prognostic factors and survival in 177 patients.

Authors:  Andreas M Stark; Hauke Tscheslog; Ralf Buhl; Janka Held-Feindt; H Maximilian Mehdorn
Journal:  Neurosurg Rev       Date:  2004-12-18       Impact factor: 3.042

8.  Breast cancer brain metastases express the sodium iodide symporter.

Authors:  Corinne Renier; Hannes Vogel; Onyinye Offor; Chen Yao; Irene Wapnir
Journal:  J Neurooncol       Date:  2009-07-19       Impact factor: 4.130

9.  The molecular biology of brain metastasis.

Authors:  Gazanfar Rahmathulla; Steven A Toms; Robert J Weil
Journal:  J Oncol       Date:  2012-03-08       Impact factor: 4.375

Review 10.  Molecular and Genetic Predictors of Breast-to-Brain Metastasis: Review and Case Presentation.

Authors:  Zachary Medress; Melanie Hayden Gephart
Journal:  Cureus       Date:  2015-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.